---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-000500"
form_type: "8-K"
ticker: null
cik: "0001289047"
company_name: "AI Technology Group Inc."
filed_at: "2026-01-29T23:59:59+00:00"
generated_at: "2026-05-16T06:18:59.052850+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# AI Technology Group Amends Merger Deal with AVM Biotech and Biomed 360, Extends Closing to July 2026

## Summary
- Amendment provides that $1M Tranche 1 convertible at $1.00/share and $1M of Tranche 2 at $2.50/share have been funded.
- Remaining three $1M Tranche 2 increments due by Feb 28, Apr 30, and Jun 30, 2026, convertible at $2.50/share.
- Tranche 3 of $10M to $25M due at closing, also convertible at $2.50/share with 10% simple interest.
- Closing date extended from March 31, 2026 to July 26, 2026 or as mutually agreed in writing.

## SEC filing metadata
- accession: 0001477932-26-000500
- form_type: 8-K
- cik: 0001289047
- company_name: AI Technology Group Inc.
- filed_at: 2026-01-29T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1289047/000147793226000500/0001477932-26-000500-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1289047/000147793226000500/aipg_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-000500
- JSON: https://secwatch.observer/filing/0001477932-26-000500.json
- Plain text: https://secwatch.observer/filing/0001477932-26-000500.txt

## Key facts
- Material Agreements
  AI Technology Group Inc. amended Agreement and Plan of Merger with AVM Biotechnology Inc. and Biomed 360 Solutions Corp. valued at Amended investment obligations and extended closing date from March 31, 2026 to July 26, 2026 (effective 2026-01-27).
  - Action: amendment
  - Agreement: merger
  - Counterparty: AVM Biotechnology Inc. and Biomed 360 Solutions Corp.
  - Value: Amended investment obligations and extended closing date from March 31, 2026 to July 26, 2026
  - Effective: 2026-01-27
  source text: On January 27, 2026, and pursuant to the Agreement and Plan of Merger , the Corporation, AVM and Biomed 360 have amended the terms of the Agreement and Plan of Merger as follows:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1289047/000147793226000500/0001477932-26-000500-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.